WINT
Closed
Windtree Therapeutics Inc
0.545
+0.029 (+5.62%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 0.5161
Day's Range: 0.46 - 0.5798
Send
sign up or login to leave a comment!
When Written:
4.52
Windtree Therapeutics Inc. is a clinical-stage biotechnology company that develops novel therapeutics for respiratory diseases and other medical conditions. The company's lead product candidate, AEROSURF, is a proprietary combination drug-device product designed to deliver aerosolized surfactant to premature infants with respiratory distress syndrome (RDS). The company is also developing KL4 surfactant for the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Windtree is headquartered in Warrington, Pennsylvania, and was founded in 1990. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol "WINT."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!